Latigo Biotherapeutics' IPO
Listed Aug 7, 2026 at $18 on Nasdaq as LTGO.
Today 15% below its $18 offer price; its first day closed +1.4%.
Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.
What does Latigo Biotherapeutics do?
“We are a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction.”
| Fact | Latigo Biotherapeutics |
|---|---|
| Incorporated | Delaware, 2018 |
| Headquarters | Thousand Oaks, California |
| Employees | 59 full-time, as of March 31, 2026 |
| Website | latigobio.com |
What is the offering?
Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.
| Fact | Latigo Biotherapeutics |
|---|---|
| Shares offered | 19,200,000 |
| Offer price | $18 a share |
| Raised at that price | $346 million |
| Underwriters' discount | $24.2 million |
| Underwriters' option | 2,880,000 more shares |
| Underwriters | Goldman Sachs, Jefferies, Leerink Partners, and Guggenheim Securities |
| Exchange | Nasdaq Global Select Market, as LTGO |
| Shares outstanding after | 63,238,030 |
| Market cap at the offer price | $1.14 billion |
What the filing says about its money
| Fact | Latigo Biotherapeutics |
|---|---|
| Revenue | None from product sales yet |
| Net loss | $109 million, year to December 31, 2025 |
| Last preferred stock | Series B preferred |
What risks does Latigo Biotherapeutics name first?
- “We are a clinical-stage biotechnology company with a limited operating history.”
- “Even if this offering is successful, we will require substantial additional financing to achieve our goals, which may cause dilution to our stockholders, and failure to obtain additional capital when needed, or on acceptable terms to us, could cause us to delay, limit, reduce…”
- “We only have two product candidates, LTG-001 and LTG-321, in clinical development.”
Every date of Latigo Biotherapeutics' IPO
| What | Day |
|---|---|
| Registration filed | Jul 17, 2026 |
| Exchange registration filed | Aug 4, 2026 |
| Declared effective by the SEC | Aug 6, 2026 |
| Priced | Aug 6, 2026 |
| First trade | Aug 7, 2026 |
| Lock-up ends | Feb 2, 2027 |
How did its first days trade?
From its daily bars, each close against its $18 offer price.
| Day | Open | Close | From the offer |
|---|---|---|---|
| Aug 7 | $21 | $18.25 | +1.4% |
| Aug 10 | $18.10 | $18.56 | +3.1% |
| Aug 11 | $18.41 | $18.52 | +2.9% |
| Aug 12 | $18.52 | $19.38 | +7.6% |
| Aug 13 | $19.46 | $20.06 | +11.4% |
What is Latigo Biotherapeutics' Quality Score?
The other IPOs expected
| Company | Price |
|---|---|
| $19 to $21 | |
| $15 to $17 | |
| $15 to $17 | |
| $7 | |
| $5 to $7 |
Latigo Biotherapeutics IPO questions
When is Latigo Biotherapeutics' IPO?
Listed Aug 7, 2026 at $18 on Nasdaq as LTGO.
What is Latigo Biotherapeutics' IPO price?
Latigo Biotherapeutics' IPO priced at $18 a share, per its final prospectus of Aug 7, 2026.
How many shares is Latigo Biotherapeutics selling?
19,200,000 shares, and the underwriters may buy 2,880,000 more, per its final prospectus (424B4).
Who are the underwriters?
Goldman Sachs, Jefferies, Leerink Partners, and Guggenheim Securities, as the prospectus's cover names them.
When does the lock-up end?
Latigo Biotherapeutics' IPO lock-up ends Feb 2, 2027. Its final prospectus says: “.”
Does Breakaway rate Latigo Biotherapeutics?
Latigo Biotherapeutics has a Quality Score of -1 today. The score counts the 14 chart checks and the company's filings; a check that needs more history than a new stock has waits for it.
Can Breakaway say where Latigo Biotherapeutics' price will go?
No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every new listing, ranked live, free. No account.
See all 16 new listings rankedSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.